- ►diabetesjournals.org DL Williams, DG Baskin, MW Schwartz - Diabetes, 2006 - Am Diabetes Assoc Leptin reduces food intake in part by enhancing satiety responses to gastrointestinal signals
produced in response to food consumption. Glucagon-like peptide 1 (GLP-1), secreted by the
intestine when nutrients enter the gut, is one such putative satiety signal. To investigate ... Cited by 18 - Related articles - BL Direct - All 9 versions
- ►endojournals.org MR Hayes, KP Skibicka, HJ Grill - Endocrinology, 2008 - Endocrine Soc The effects of peripheral glucagon like peptide-1 receptor (GLP-1R) stimulation on feeding, gastric
emptying, and energetic responses involve vagal transmission and central nervous system
processing. Despite a lack of studies aimed at determining which central nervous system ... Cited by 12 - Related articles - All 6 versions
- ►endojournals.org TP Vahl, M Tauchi, TS Durler, EE Elfers, TM Fernandes … - Endocrinology, 2007 - Endocrine Soc Glucagon-like peptide-1 (GLP-1) is an intestinal hormone that is secreted during meal absorption
and is essential for normal glucose homeostasis. However, the relatively low plasma levels and
rapid metabolism of GLP-1 raise questions as to whether direct endocrine action on target ... Cited by 28 - Related articles - BL Direct - All 2 versions
- ►endojournals.org L Huo, KM Gamber, HJ Grill, C Bjorbaek - Endocrinology, 2008 - Endocrine Soc The central targets mediating the anorectic and other actions of leptin have yet to be fully
identified. Although previous studies focused on the hypothalamus, leptin also acts on neurons
in extrahypothalamic sites, including the nucleus of the solitary tract (NTS). Moreover, ... Cited by 5 - Related articles - BL Direct - All 5 versions
DL Williams, DG Baskin, MW Schwartz - Endocrinology, 2009 - Endocrine Soc A physiological role in satiety is proposed for glucagon-like peptide-1 (GLP-1), secreted by the
distal intestine in response to ingested nutrients. Here we report that in rats, ip injection of the
GLP-1 receptor (GLP-1-R) antagonist exendin 9-39 (Ex9) elicited hyperphagia, but only at ... Cited by 7 - Related articles - All 3 versions
- ►physiology.org PK Chelikani, AC Haver, RD … - American Journal of …, 2005 - Am Physiological Soc Glucagon-like peptide-1(7–36)-amide (GLP-1) is postulated to act as a hormonal signal from
gut to brain to inhibit food intake and gastric emptying. A mixed-nutrient meal produces a 2 to
3-h increase in plasma GLP-1. We determined the effects of intravenous infusions of ... Cited by 29 - Related articles - All 4 versions
EB Ruttimann, M Arnold, JJ Hillebrand, N Geary, W … - Endocrinology, 2009 - Endocrine Soc Peripheral administration of glucagon-like peptide (GLP)-1 reduces food intake in animals and
humans, but the sites and mechanism of this effect and its physiological significance are not
yet clear. To investigate these issues, we prepared rats with chronic catheters and infused ... Cited by 3 - Related articles - All 2 versions
C Knauf, PD Cani, DH Kim, MA Iglesias, C Chabo, A … - Diabetes, 2008 - Am Diabetes Assoc OBJECTIVE—Ingested glucose is detected by specialized sensors in the enteric/hepatoportal
vein, which send neural signals to the brain, which in turn regulates key peripheral tissues.
Hence, impairment in the control of enteric-neural glucose sensing could contribute to ... Cited by 13 - Related articles - All 8 versions
